Description
Humana Press Inc. Essentials Of Restenosis For The Interventional Cardiologist by Henricus J. Duckers
Leading interventional cardiologists, including Patrick Serruys, provide the gold-standard reference on the treatment of restenosis for interventional cardiologists. Dr. Serruys, who pioneered the use of drug-eluting stents, and other pioneers in the field, cover everything from non-invasive imaging, to eluting stents, to brachytherapy through to the latest molecular biology-based treatments including antisense, stem cells and gene therapy._x000D_ _x000D_
Essentials of Restenosis for the Interventional Cardiologist_x000D_
Table of Contents:_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Part A. Introduction_x000D_
_x000D_
Henricus J. Duckers_x000D_
Caroline Cheng_x000D_
Dennie Tempel_x000D_
Patrick W. Serruys_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Part B. Pathophysiology and Diagnosis_x000D_
_x000D_
Chapter:_x000D_
_x000D_
1. Epidemiology and Pathogenesis of Restenosis Randolph L. Geary_x000D_
Alexander W. Clowes_x000D_
_x000D_
2. Clinical Presentation of Restenosis Ganesh Manoharan_x000D_
Giedrius Davidavicius_x000D_
William Wijns_x000D_
_x000D_
3. Pathologic Anatomy of Restenosis Renu Virmani_x000D_
Frank D. Kolodgie_x000D_
Aloke V. Finn_x000D_
Herman K. Gold_x000D_
_x000D_
4. The Influence of Shear Stress on Restenosis Attila Thury_x000D_
Cornelis J. Slager et al._x000D_
_x000D_
5. Role of the Immune System in the_x000D_
Pathogenesis of Vascular Proliferative Disease Jon D. Laman_x000D_
Burkhard Ludewig _x000D_
_x000D_
6. Animal Restenosis Models._x000D_
From the aEUROoeIdeal ModelaEURO? to the aEUROoeIdeal StudyaEURO? Arturo G. Touchard_x000D_
Robert S. Schwartz_x000D_
_x000D_
_x000D_
_x000D_
Part C. Genetic base of restenosis_x000D_
_x000D_
Chapter:_x000D_
_x000D_
7. The Genomics of Restenosis Thomas W. Johnson_x000D_
Karl R. Karsch_x000D_
_x000D_
8. Gene Expression Profiling and Restenosis Dietlind ZohlnhAfer_x000D_
Franz-Josef Neumann_x000D_
_x000D_
9. Proteomics and Restenosis Santhi K. Ganesh_x000D_
Elizabeth G. Nabel_x000D_
_x000D_
10. Contribution of circulating Progenitor Cells to_x000D_
Vascular Repair and Lesion Formation. Masataka Sata_x000D_
Kenneth Walsh_x000D_
_x000D_
11. Cell Cycle Regulation in Vascular_x000D_
Proliferative Diseases Andrew Wragg_x000D_
Manfred Boehm_x000D_
_x000D_
12. Arterial Remodelling Gerard Pasterkamp_x000D_
Bradley H. Strauss_x000D_
_x000D_
Dominique de Kleijn_x000D_
_x000D_
_x000D_
13. The role of eNOS in vascular diseases Alexey Kuroedov_x000D_
Francesco Cosentino_x000D_
Felix C. Tanner_x000D_
Thomas LA1/4scher_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Part D. Diagnostics of Restenosis_x000D_
_x000D_
Chapter:_x000D_
_x000D_
14. The use of pressure gradient analysis in the_x000D_
diagnosis of restenosis Volker Klaus_x000D_
Nico N.H.J. Pijls_x000D_
_x000D_
15. The Use of Radio Isotopes in the Diagnosis_x000D_
ofVascular Proliferative Disease Giedrius Davidavicius_x000D_
Ganesh Manoharan_x000D_
William Wijns_x000D_
_x000D_
16. Magnetic resonance imaging for restenosis Robert Jan M. van_x000D_
Geuns_x000D_
Timo Baks_x000D_
_x000D_
_x000D_
17. Coronary Imaging with Multislice Spiral_x000D_
Computed Tomography Koen Nieman_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Part E. Therapy of Restenosis_x000D_
_x000D_
Chapter:_x000D_
_x000D_
18. Pharmacotherapy of Restenosis Pim J. de Feyter_x000D_
Georgios Sianos_x000D_
_x000D_
19. Brachytherapy Ron Waksman_x000D_
_x000D_
_x000D_
20. Pre-clinical Data of Eluting Stents Antonio Colombo_x000D_
Alaide Chieffo_x000D_
_x000D_
21. Clinical Data of Eluting Stents Marco A. Costa_x000D_
Alexandre Abizaid_x000D_
Amanda G.M.R. Sousa_x000D_
Eduardo Sousa_x000D_
_x000D_
22. Biodegradable stents Takafumi Tsuji_x000D_
Hideo Tamai_x000D_
_x000D_
Keiji Igaki_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Part F. Biotechnology in the Treatment of Restenosis_x000D_
_x000D_
Chapter:_x000D_
_x000D_
23. Vascular Gene Therapy Gurpreet S. Sandhu_x000D_
Robert D. Simari _x000D_
_x000D_
24. Antisense and ODN transcription factors_x000D_
in the treatment of Vascular Proliferative Disease Nicholas Kipshidze_x000D_
Mykola Tsapenko_x000D_
George Dangas_x000D_
Pat Iversen_x000D_
_x000D_
25. Cell Cycle Approaches to the_x000D_
Treatment of In-stent Restenosis Elizabeth G. Nabel_x000D_
_x000D_
26. Local Gene and Cell Delivery Devices Ravish Sachar_x000D_
Eric J. Topol_x000D_